A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 y

Julkaisu

Reference

Vesikari T, Forstén A, Boutriau D, et al. A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 y. Hum Vaccin Immunother 2012:8(12):1882-1891.

Julkaisutiedot

Julkaisutyyppi: Alkuperäisartikkeli.
Kansainvälinen.
Kieli: Englanti.

Teksti/tiivistelmä: https://www.ncbi.nlm.nih.gov/pubmed/23032168

Publication data

Publication type: Original scientific article.
International.
In English.

Text/summary: https://www.ncbi.nlm.nih.gov/pubmed/23032168

Tekijät

Contributors

Tampereen yliopisto

Lääketieteen laitos/virologia 1
- Timo Vesikari

University of Tampere

Medical School/Department of Virology 1
- Timo Vesikari

Tampereen yliopistollinen sairaala

Lastentautien vastuualue
- Timo Vesikari

Tampere University Hospital

Julkaisutietokanta 16.10.2013

Publications Data Base 16.10.2013